Precision BioSciences is developing mulitple DNE therapeutics targeted to enable the precise in situ correction of genes responsible for human disease.
More about BioTherapeutics >>
Engineered DNE meganucleases are being used to engineer cell lines for disease models or optimize cell lines for the biomanufacturing of protein vaccines and therapeutics.
More about BioTools >>
Custom DNE meganucleases produced by Precision BioSciences enable site-specific engineering of row crops and biofuel feedstocks.
More about PlantSciences >>
Precision BioSciences Wins Patent Infringement Lawsuit against Cellectis
Precision BioSciences Awarded Patent for Genetically Modifying Cells
Precision BioSciences and DuPont Detail Technology Efficacy in The Plant Journal